These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5604513)

  • 1. [Bladder catherization and nalidixic acid].
    Quiñones R; Luna del Villar J; Padilla F; Martinez Zalce G
    Ginecol Obstet Mex; 1967; 22(127):97-107. PubMed ID: 5604513
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nalidixic acid in the treatment of urinary tract infections. Preliminary results].
    Busilacchi M; Verzetti G; Pagano G; Emanuelli G
    Clin Ter; 1968 Mar; 44(5):413-9. PubMed ID: 5739593
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of nalidixic acid in urinary infections].
    Wemeau L; Declerco M
    Lille Med; 1976 Sep; 21(7 Suppl 3):591-4. PubMed ID: 994688
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical study of nalidixic acid in urinary tract sepsis].
    Piacentini L
    Minerva Urol; 1968; 20(3):123-30. PubMed ID: 5743163
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical contribution to the use of nalidixic acid in urinary infections].
    Zambarda E
    Acta Gerontol (Milano); 1968; 18(1):50-63. PubMed ID: 5715920
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention and therapy of urinary tract infection due to indwelling catheterization (following vaginal surgery) with special reference to follow-up studies].
    Keller U
    Zentralbl Gynakol; 1973 Nov; 95(47):1663-8. PubMed ID: 4773769
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug-resistant organisms in urinary tract infections and clinical use of Wintomylon (nalidixic acid)].
    Kuze M; Kashiwagi T; Okita J; Komiya T; Nihira H
    Hinyokika Kiyo; 1966 Mar; 12(3):291-6. PubMed ID: 6006673
    [No Abstract]   [Full Text] [Related]  

  • 8. [Nalidixic acid (Neggram) in the treatment of chronic non-specific urinary tract infections].
    Porpáczy P; Haschek H; Zischka-Konorsa W; Hermanek P; Bibus B
    Wien Klin Wochenschr; 1968 Feb; 80(5):87-93. PubMed ID: 5667719
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical use of Wintomylon for urinary tract infections (mainly in spinal cord injuries)].
    Tamai T; Hashimoto H; Goto K; Imamura T; Haraguchi H
    Seikei Geka; 1967 May; 18(6):571-6. PubMed ID: 6071091
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical evaluation of Wintomylon (nalidixic acid) in the urinary tract infections].
    Yamasaki I; Kato T; Ogawa T
    Hinyokika Kiyo; 1965 Sep; 11(9):913-34. PubMed ID: 5324475
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of antibacterial activity of oxolinic acid (Gramurin) and nalidixic acid (Nevigramon) in vitro and in patients with urinary tract infections].
    Manitius A; Hebanowski M; Galiński J; Nowicki B
    Pol Tyg Lek; 1978 Aug; 33(34):1347-50. PubMed ID: 704439
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the treatment of urinary tract infections with nalidixic acid].
    Baumann W; Gruhn I
    Dtsch Gesundheitsw; 1967 Jan; 22(4):159-63. PubMed ID: 5582766
    [No Abstract]   [Full Text] [Related]  

  • 13. [Nalidixic acid in chronic urinary tract infections].
    Gasser G; Neuhold R
    Wien Med Wochenschr; 1967 Mar; 117(8):192-6. PubMed ID: 5589339
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experimentation with nalidixic acid in urology].
    Auvray P
    Acta Urol Belg; 1965 Oct; 33(4):563-76. PubMed ID: 5859504
    [No Abstract]   [Full Text] [Related]  

  • 15. Observations on the clinical use of nalidixic acid.
    Stamey TA
    Postgrad Med J; 1971 Sep; 47():Suppl:21-6. PubMed ID: 5112308
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical use of Wintomylon (nalidixic acid) in the field of urology].
    Gotoh K; Shinoda T; Ito S; Isogai K; Kimura T; Ohtani F; Ishiyama K
    Hinyokika Kiyo; 1965 Oct; 11(10):1011-4. PubMed ID: 5324357
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of nalidixic acid (Wintomylon) for the treatment of urinary tract infections].
    Ohori T; Koshiba K; Goto Y; Ujiie K; Kasahara N
    Hinyokika Kiyo; 1965 Jul; 11(7):677-84. PubMed ID: 5319354
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-term treatment of urinary tract infections with nalidixide acid].
    Sogaard-Andersen J; Alsner T
    Ugeskr Laeger; 1967 Jun; 129(24):785-7. PubMed ID: 5599838
    [No Abstract]   [Full Text] [Related]  

  • 19. [The use of Wintomylon in urinary infections. Observations on 50 patients].
    Ferreira AA
    Hospital (Rio J); 1966 Nov; 70(5):1313-7. PubMed ID: 5301946
    [No Abstract]   [Full Text] [Related]  

  • 20. [A clinical evaluation of Wintomylon in the treatment of urinary infections].
    Inada T; Ebisuta K; Kitayama T; Miyakawa M
    Hinyokika Kiyo; 1966 Oct; 12(10):1150-5. PubMed ID: 6008094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.